Homoharringtonine production by endophytic fungus isolated from Cephalotaxus hainanensis Li

• DOI: 10.1007/s11274-016-2073-9
• Publication Date: 2016-06-04T05:17:49Z
• Authors: Xiaoping Hu; Wu Li; Mu Yuan; Congfa Li; Sixin Liu; Chunjie Jiang; Yanchun Wu; Kun Cai; Yan Liu
• Keywords: Harringtonines; 0303 health sciences; Alternaria; Antineoplastic Agents; HL-60 Cells; Cephalotaxus; 3. Good health; 03 medical and health sciences; Alkaloids; Leukemia, Promyelocytic, Acute; Cell Line, Tumor; Fermentation; Endophytes; Humans; Drug Screening Assays, Antitumor; Homoharringtonine; K562 Cells

Homoharringtonine (HHT), a natural plant alkaloid derived from Cephalotaxus, has demonstrated to have a broad antitumor activity and efficacy in treating human chronic myeloid leukemia. An alternative source is required to substitute for the slow-growing and scarce Cephalotaxus to meet the increasing demand of the drug market. The objective of this study was to screen HHT-producing endophytic fungi from Cephalotaxus hainanensis Li. By screening 213 fungal isolates obtained from the bark parts of Cephalotaxus hainanensis Li, one isolate was found to be capable of biosynthesizing HHT. The fungus was identified as Alternaria tenuissima by morphological characteristics and internal transcribed spacer (ITS) sequence analysis and was named as CH1307. HHT obtained from CH1307 was analyzed through the HPLC and LC-MS/MS and NMR spectroscopy. The extract of the fermentation broth of CH1307 showed antiproliferative activities against K562 (chronic myelocytic leukemia), NB4 (acute promyelocytic leukemia), and HL-60 (promyelocytic leukemia) human cancer cell lines with IC50 values of 67.25 ± 4.26, 65.02 ± 4.75, and 99.23 ± 4.26 μg/mL, respectively. The findings suggest that HHT-producing endophytic fungus, Alternaria tenuissima CH1307 might provide a promising source for the research and application of HHT.